608 related articles for article (PubMed ID: 29936118)
41. Doping hydroxylated cationic lipid into PEGylated cerasome boosts in vivo siRNA transfection efficacy.
Li Y; Zheng S; Liang X; Jin Y; Wu Y; Bai H; Liu R; Dai Z; Liang Z; Shi T
Bioconjug Chem; 2014 Nov; 25(11):2055-66. PubMed ID: 25260060
[TBL] [Abstract][Full Text] [Related]
42. Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape.
Gilleron J; Querbes W; Zeigerer A; Borodovsky A; Marsico G; Schubert U; Manygoats K; Seifert S; Andree C; Stöter M; Epstein-Barash H; Zhang L; Koteliansky V; Fitzgerald K; Fava E; Bickle M; Kalaidzidis Y; Akinc A; Maier M; Zerial M
Nat Biotechnol; 2013 Jul; 31(7):638-46. PubMed ID: 23792630
[TBL] [Abstract][Full Text] [Related]
43. Delivery of siRNA Complexed with Palmitoylated α-Peptide/β-Peptoid Cell-Penetrating Peptidomimetics: Membrane Interaction and Structural Characterization of a Lipid-Based Nanocarrier System.
Jing X; Foged C; Martin-Bertelsen B; Yaghmur A; Knapp KM; Malmsten M; Franzyk H; Nielsen HM
Mol Pharm; 2016 Jun; 13(6):1739-49. PubMed ID: 26654841
[TBL] [Abstract][Full Text] [Related]
44. Efficient siRNA Delivery by Lipid Nanoparticles Modified with a Nonstandard Macrocyclic Peptide for EpCAM-Targeting.
Sakurai Y; Mizumura W; Murata M; Hada T; Yamamoto S; Ito K; Iwasaki K; Katoh T; Goto Y; Takagi A; Kohara M; Suga H; Harashima H
Mol Pharm; 2017 Oct; 14(10):3290-3298. PubMed ID: 28789523
[TBL] [Abstract][Full Text] [Related]
45. Development of Cationic Quaternary Ammonium Sulfonamide Amino Lipids for Nucleic Acid Delivery.
Miller JB; Kos P; Tieu V; Zhou K; Siegwart DJ
ACS Appl Mater Interfaces; 2018 Jan; 10(3):2302-2311. PubMed ID: 29286232
[TBL] [Abstract][Full Text] [Related]
46. Cationic lipid-coated gold nanoparticles as efficient and non-cytotoxic intracellular siRNA delivery vehicles.
Kong WH; Bae KH; Jo SD; Kim JS; Park TG
Pharm Res; 2012 Feb; 29(2):362-74. PubMed ID: 21842305
[TBL] [Abstract][Full Text] [Related]
47. Hyaluronan grafted lipid-based nanoparticles as RNAi carriers for cancer cells.
Landesman-Milo D; Goldsmith M; Leviatan Ben-Arye S; Witenberg B; Brown E; Leibovitch S; Azriel S; Tabak S; Morad V; Peer D
Cancer Lett; 2013 Jul; 334(2):221-7. PubMed ID: 22935680
[TBL] [Abstract][Full Text] [Related]
48. One-Step Production Using a Microfluidic Device of Highly Biocompatible Size-Controlled Noncationic Exosome-like Nanoparticles for RNA Delivery.
Kimura N; Maeki M; Ishida A; Tani H; Tokeshi M
ACS Appl Bio Mater; 2021 Feb; 4(2):1783-1793. PubMed ID: 35014524
[TBL] [Abstract][Full Text] [Related]
49. Glycerol monooleate-based nanocarriers for siRNA delivery in vitro.
Zhen G; Hinton TM; Muir BW; Shi S; Tizard M; McLean KM; Hartley PG; Gunatillake P
Mol Pharm; 2012 Sep; 9(9):2450-7. PubMed ID: 22794355
[TBL] [Abstract][Full Text] [Related]
50. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy.
Mo RH; Zaro JL; Shen WC
Mol Pharm; 2012 Feb; 9(2):299-309. PubMed ID: 22171592
[TBL] [Abstract][Full Text] [Related]
51. Microfluidic-Based Holonomic Constraints of siRNA in the Kernel of Lipid/Polymer Hybrid Nanoassemblies for Improving Stable and Safe In Vivo Delivery.
Wei W; Sun J; Guo XY; Chen X; Wang R; Qiu C; Zhang HT; Pang WH; Wang JC; Zhang Q
ACS Appl Mater Interfaces; 2020 Apr; 12(13):14839-14854. PubMed ID: 32182035
[TBL] [Abstract][Full Text] [Related]
52. Influence of lipoplex surface charge on siRNA delivery: application to the in vitro downregulation of CXCR4 HIV-1 co-receptor.
Lavigne C; Slater K; Gajanayaka N; Duguay C; Arnau Peyrotte E; Fortier G; Simard M; Kell AJ; Barnes ML; Thierry AR
Expert Opin Biol Ther; 2013 Jul; 13(7):973-85. PubMed ID: 23289797
[TBL] [Abstract][Full Text] [Related]
53. A Combinatorial Library of Lipid Nanoparticles for RNA Delivery to Leukocytes.
Ramishetti S; Hazan-Halevy I; Palakuri R; Chatterjee S; Naidu Gonna S; Dammes N; Freilich I; Kolik Shmuel L; Danino D; Peer D
Adv Mater; 2020 Mar; 32(12):e1906128. PubMed ID: 31999380
[TBL] [Abstract][Full Text] [Related]
54. Poly(lactide-
Wu L; Wu LP; Wu J; Sun J; He Z; Rodríguez-Rodríguez C; Saatchi K; Dailey LA; Häfeli UO; Cun D; Yang M
ACS Appl Mater Interfaces; 2021 Jan; 13(3):3722-3737. PubMed ID: 33439616
[TBL] [Abstract][Full Text] [Related]
55. On the Formation and Morphology of Lipid Nanoparticles Containing Ionizable Cationic Lipids and siRNA.
Kulkarni JA; Darjuan MM; Mercer JE; Chen S; van der Meel R; Thewalt JL; Tam YYC; Cullis PR
ACS Nano; 2018 May; 12(5):4787-4795. PubMed ID: 29614232
[TBL] [Abstract][Full Text] [Related]
56. Light-Activated siRNA Endosomal Release (LASER) by Porphyrin Lipid Nanoparticles.
Mo Y; Cheng MHY; D'Elia A; Doran K; Ding L; Chen J; Cullis PR; Zheng G
ACS Nano; 2023 Mar; 17(5):4688-4703. PubMed ID: 36853331
[TBL] [Abstract][Full Text] [Related]
57. Hydrophobic interactions between polymeric carrier and palmitic acid-conjugated siRNA improve PEGylated polyplex stability and enhance in vivo pharmacokinetics and tumor gene silencing.
Sarett SM; Werfel TA; Chandra I; Jackson MA; Kavanaugh TE; Hattaway ME; Giorgio TD; Duvall CL
Biomaterials; 2016 Aug; 97():122-32. PubMed ID: 27163624
[TBL] [Abstract][Full Text] [Related]
58. Enhancing siRNA delivery by employing lipid nanoparticles.
Hope MJ
Ther Deliv; 2014 Jun; 5(6):663-73. PubMed ID: 25090280
[TBL] [Abstract][Full Text] [Related]
59. Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA.
Yang XZ; Dou S; Wang YC; Long HY; Xiong MH; Mao CQ; Yao YD; Wang J
ACS Nano; 2012 Jun; 6(6):4955-65. PubMed ID: 22646867
[TBL] [Abstract][Full Text] [Related]
60. Noninvasive imaging of lipid nanoparticle-mediated systemic delivery of small-interfering RNA to the liver.
Tao W; Davide JP; Cai M; Zhang GJ; South VJ; Matter A; Ng B; Zhang Y; Sepp-Lorenzino L
Mol Ther; 2010 Sep; 18(9):1657-66. PubMed ID: 20628357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
